Nasdaq, Inc.: Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date December 15, 2025

At the end of the settlement date of December 15, 2025, short interest in 3,486 Nasdaq Global MarketSM securities totaled ...

Xali Gold Corp.: Xali Gold Closes Acquisition of Pico Machay Gold Project

Xali Gold Corp. (TSXV:XGC) ("Xali Gold" or the "Company") is very pleased to announce the closing on December 24th, 2025, of ...

Johnson Fistel, PLLP: Coupang, Inc. (NYSE: CPNG): Johnson Fistel Investigates Data Breach Disclosures Following Multiple Stock Drops

Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Coupang, Inc. (NYSE: CPNG) or certain of its officers ...

CompoSecure, Inc. today announced that its stockholders have approved the issuance of shares of CompoSecure Class A Common Stock in connection with the proposed business ...

CompoSecure, Inc. (NYSE: CMPO) today announced that its stockholders have approved the issuance of shares of CompoSecure Class A Common Stock in connection ...

ExGen Resources Inc: ExGen Signs Another Binding LOI to Acquire a Second Silver Stream on Past-Producing Gold Mine

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 24, 2025 (GLOBE NEWSWIRE) -- ExGen Resources Inc. (TSX.V: EXG; OTC: ...

M2i Global, Inc.: M2i Global, along with Volato Group, Issues Year End Shareholder Letter, Providing Highlights Achieved in 2025

Strategic Roadmap is Set for Further Advancing the Business and Capital Markets Plans in 2026 Atlanta, GA and Reno, NV, Dec. 24, 2025 (GLOBE NEWSWIRE) -- M2i Global, Inc. ("M2i," the "Company," "we," ...

Caliway Biopharmaceuticals: Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding ...

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 ...

Crazy Woman Creek Bancorp, Inc.: Crazy Woman Creek Bancorp Reports Earnings for Fiscal Year 2025; Declares Annual Cash Dividend of $0.32 Per Share

We continue to build our franchise as Crazy Woman Creek Bancorp (OTCPink: CRZY) and Buffalo Federal Bank, known as The Banks of Buffalo, Sheridan, Gillette ...

Biohaven Ltd.: Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive Disorder

Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization ...

WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025

WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary, Work ...

Edgewise Therapeutics Announces Completion of the EDG-7500 CIRRUS-HCM Phase 2 Parts B and C and Favorable Interim Safety Results from the Ongoing Part D Study in Hypertrophic ...

In the CIRRUS-HCM trial, including interim safety results from Part D, EDG-7500 was generally well tolerated; no clinically meaningful reductions in LVEF or LVEF - - On track to deliver ...

ImmuCell Corporation: ImmuCell Announces Strategic Focus on First Defense After Receiving an FDA Incomplete Letter for Re-Tain

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell"), an animal health company that develops, manufactures and markets products that improve cattle health ...